Originally Published: July 15, 2014
Introduction
A major, if not the major, driver of advances in medicine is the development of better diagnostics. The ability to diagnose disease is required before new therapies can be developed or, in many cases, even conceived. Of course the foundation for diagnostics is solid basic science, which provides the insight needed to understand what can and should be diagnosed. The application of the basic science to a well-defined problem requires engineering. Good engineering is needed to manufacture appropriate diagnostics, including both the introduction of new materials and manufacturing practices but also to ensure ease of use and cost effectiveness. For diagnostics the holy grail is cheap, fast and accurate but all three are rarely achieved. However, combining new technologies and better understanding of biological processes is driving advances to achieve the three goals.
Want to read the rest of the article? Fill out the form to download: New Diagnostics in Medicine – Cheap, Fast, and Accurate
<
Related Posts
- 77By Stephen Buxser, Ph.D. Nerac Analyst Originally Published: July 21, 2014 A revolution is well underway in the development and application of new nucleic acid sequencing technologies. New techniques have been developed that have profoundly increased the rate at which whole genomes and nearly any other form of DNA or RNA can be rapidly and accurately…
- 32By Roz Sweeney, Ph.D. Nerac Analyst, The recent Supreme Court decision on the Association for Molecular Pathology v. Myriad Genetics case was the culmination of much litigation on the validity of patent protection for the genomic sequences of BRCA1 and BRCA2. Myriad Genetics’ patents on these two genes gave it the exclusive right to offer genetic…
- 30By John Leavitt, Ph.D. Nerac Analyst Originally Published: August 12, 2014 In 1987, my colleagues at Stanford and I published a paper that clearly demonstrated that expression of a charge-altered mutant human beta-actin (glycine to aspartic acid substitution at amino acid 245; G245D) caused non-tumorigenic, immortalized human fibroblasts to form aggressive tumors in nude mice (Leavitt…